Treatment of Eosinophilic Annular Erythema With Benralizumab
JAMA Dermatology · 2023
DOI: 10.1001/jamadermatol.2023.0314 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, 2023. Verfasst von Fernando Moro-Bolado und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Ciudad Real University General Hospital, Ciudad Real, Spain. Hauptthemen laut MEDLINE: Erythema, Skin Diseases, Genetic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
This case report describes an 83-year-old woman with a generalized pruritic eruption comprising annular and polycyclic plaques on the face, neck, trunk, and extremities with changing appearance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatology Department, Ciudad Real University General Hospital, Ciudad Real, Spain.
- Allergology Department, Ciudad Real University General Hospital, Ciudad Real, Spain.
Zitieren
APA
Moro-Bolado, F., Martínez-Montalvo, L., Al-Wattar-Ceballos, O., Galindo-Bonilla, P. Á., & García-Arpa, M. (2023). Treatment of Eosinophilic Annular Erythema With Benralizumab. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2023.0314
Vancouver
Moro-Bolado F, Martínez-Montalvo L, Al-Wattar-Ceballos O, Galindo-Bonilla PÁ, García-Arpa M. Treatment of Eosinophilic Annular Erythema With Benralizumab. JAMA Dermatology. 2023. doi:10.1001/jamadermatol.2023.0314
BibTeX
@article{MoroBolado2023,
author = {Moro-Bolado, Fernando and Martínez-Montalvo, Laura and Al-Wattar-Ceballos, Omar and Galindo-Bonilla, Pedro Ángel and García-Arpa, Mónica},
title = {Treatment of Eosinophilic Annular Erythema With Benralizumab},
journal = {JAMA Dermatology},
year = {2023},
doi = {10.1001/jamadermatol.2023.0314}
}
EUVIMED